BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 5138128)

  • 1. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A; Vereecken JL
    Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluspirilene, a long-acting injectable neuroleptic.
    Ciccarelli G; Nosé F; Zuanazzi GF
    Acta Psychiatr Belg; 1972 Nov; 72(6):736-47. PubMed ID: 4679675
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long term neuroleptic therapy using fluspirilene and penfluridol].
    Haase HJ; Fischer D; Floru L; Frank T; Joseph K; Knaack M; Mohr W; Richter-Peill H; Steuer A; Wahl G; Walterbusch G; Zurborn R
    Nervenarzt; 1971 Dec; 42(12):632-7. PubMed ID: 5134761
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluspirilene in the treatment of chronic schizophrenic outpatients.
    St-Laurent J; Carle R; Domingue D
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):599-608. PubMed ID: 4628682
    [No Abstract]   [Full Text] [Related]  

  • 5. [The depot neuroleptic agent fluspirilene (author's transl)].
    Angst J; Frei M; Scharfetter Chr
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):13-28. PubMed ID: 4602371
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with fluspirilene in psychoses.
    Svestka J; Náhunek K; Hádlík J; Rodová A
    Act Nerv Super (Praha); 1971; 13(3):173-4. PubMed ID: 5113825
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of a neuroleptic with prolonged action (fluspirilene)].
    De Francisco CP; Nieto Gómez D; Castilla J; Torres A; Avalos C
    Actas Luso Esp Neurol Psiquiatr; 1971; 30(3):123-8. PubMed ID: 5145187
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experimentation with a long-acting neuroleptic fluspirilene (R 6218)].
    Luyckx A
    Acta Psychiatr Belg; 1972 Nov; 72(6):748-55. PubMed ID: 4679557
    [No Abstract]   [Full Text] [Related]  

  • 9. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 10. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 11. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
    Faltus F
    Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
    Gálfi B; Benson K; Grynaeus T
    Int Pharmacopsychiatry; 1973; 8(1):37-59. PubMed ID: 4595192
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
    Angst J; Woggon B
    Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Initial results of clinical trial of a new long-acting neuroleptic agent: Fluspirelene].
    Ciccarelli G; Nosè F
    Minerva Med; 1971 Dec; 62(98):4922-7. PubMed ID: 5141918
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of the long-acting injectable neuroleptic, fluspirilene, in the treatment of schizophrenic and mentally retarded patients.
    Zwanikken GJ; Remans B; Dewulf P; Amery W
    Acta Psychiatr Scand; 1971; 47(3):334-48. PubMed ID: 4946910
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluspirilene in the treatment of chronic schizophrenic patients.
    Chouinard G; Ban TA; Lehmann HE; Ananth JV
    Curr Ther Res Clin Exp; 1970 Sep; 12(9):604-8. PubMed ID: 4989692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-acting antiparkinson agents. I. Pilot study on benzetimide (342 cases)].
    Korn M; Pinchard A; Breulet M; Goffioul F; Bobon J
    Acta Psychiatr Belg; 1971 Mar; 71(2):65-75. PubMed ID: 5560276
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.
    Ota KY; Kurland AA; Slotnick VB
    J Clin Pharmacol; 1974 Apr; 14(4):202-9. PubMed ID: 4595986
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical study of an injectable long-acting neuroleptic agent: fluspirilene (R 6218).
    Onkenhout LA; Scheffer W; Amery W
    Psychiatr Neurol Neurochir; 1970; 73(4):285-91. PubMed ID: 5478772
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of fluspirilene as a maintenance therapy in chronic schizophrenic patients.
    Singh AN
    Can Psychiatr Assoc J; 1973 Oct; 18(5):415-9. PubMed ID: 4746145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.